Eli Lilly, Sitryx announce autoimmune alliance
Eli Lilly recently announced plans to postpone most new COVID-19-unrelated study starts.
Read More
Tag: immunometabolism
New UK biopharma Sitryx launches with $30m fundraising
New UK biopharmaceutical group Sitryx has launched operations with $30 million to help it develop disease-modifying therapeutics in immunometabolism.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
